Model-Dependent Attenuation of Seizures by Cinnabar
- PMID: 40783890
- DOI: 10.1007/s12264-025-01480-7
Model-Dependent Attenuation of Seizures by Cinnabar
Abstract
Epilepsy is one of the most prevalent and severe neurological disorders, and it is inadequately controlled with currently available medications. While cinnabar (mercury(II) sulfide)-a traditional Chinese medicine-has historical application in epilepsy treatment, its therapeutic efficacy and underlying mechanisms are unclear. In this study, we find that cinnabar exerts model-dependent antiseizure efficacy in mice. Specifically, it significantly attenuates acute seizures, enhances the termination of diazepam-resistant status epilepticus, and reduces spontaneous seizures in the kainic acid (KA)-induced seizure model. Conversely, no therapeutic effect was found in the maximal electroshock-, pentylenetetrazole-, or kindling-induced seizure model. Fiber photometry revealed that cinnabar normalizes KA-induced hippocampal neurotransmission imbalances by simultaneously decreasing glutamate hyperactivity and γ-aminobutyric acid hypoactivity. Furthermore, cinnabar has neuroprotective effects and alleviates comorbid anxiety-like behaviors, while showing no alterations in motor function. Our findings suggest cinnabar's potential as a therapeutic agent for seizure management, via a mechanism associated with the reversal of the hippocampal excitatory/inhibitory imbalance.
Keywords: Anxiety; Cinnabar; Epilepsy; Kainic acid.
© 2025. Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences.
Conflict of interest statement
Conflict of interest: The authors declare that there are no conflicts of interest.
Similar articles
-
Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.Cochrane Database Syst Rev. 2018 Jan 10;1(1):CD001905. doi: 10.1002/14651858.CD001905.pub3. Cochrane Database Syst Rev. 2018. PMID: 29320603 Free PMC article.
-
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Jul 18;7:CD001911. doi: 10.1002/14651858.CD001911.pub4. PMID: 28240353 Free PMC article. Updated.
-
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2015 Aug 14;(8):CD001911. doi: 10.1002/14651858.CD001911.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Feb 27;2:CD001911. doi: 10.1002/14651858.CD001911.pub3. PMID: 26275105 Updated.
-
Yoga for epilepsy.Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD001524. doi: 10.1002/14651858.CD001524.pub3. Cochrane Database Syst Rev. 2017. PMID: 28982217 Free PMC article.
-
Vitexin Alleviates Kainic Acid-Induced Seizure Through Inhibiting P2X7R/NLRP3 Signaling Pathway.Inflammation. 2025 Jun 30. doi: 10.1007/s10753-025-02324-2. Online ahead of print. Inflammation. 2025. PMID: 40586851
References
-
- Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet 2019, 393: 689–701. - PubMed
-
- Löscher W, Klitgaard H, Twyman RE, Schmidt D. New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 2013, 12: 757–776. - PubMed
-
- Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011, 52: 2–26. - PubMed
-
- Wang Y, Chen Z. An update for epilepsy research and antiepileptic drug development: toward precise circuit therapy. Pharmacol Ther 2019, 201: 77–93. - PubMed
-
- Mesraoua B, Brigo F, Lattanzi S, Abou-Khalil B, Al Hail H, Asadi-Pooya AA. Drug-resistant epilepsy: definition, pathophysiology, and management. J Neurol Sci 2023, 452: 120766. - PubMed
LinkOut - more resources
Full Text Sources